HCPCS drug code · CMS crosswalk
Phenylephrine HCl J-Code / HCPCS Code
In short
Phenylephrine HCl is billed under HCPCS J2371 — Injection, phenylephrine hydrochloride, 20 micrograms. One billing unit is 20 mcg. CMS's crosswalk lists 57 Phenylephrine HCl NDCs under this code.
Reference
- J2371
- Injection, phenylephrine hydrochloride, 20 microgramsBilling unit: 20 mcg
- Labelers
- Amneal Pharmaceuticals, LLC; Apollo Pharmaceuticals; Apollo Pharmaceuticals Inc.; Armas Pharmaceuticals Inc.; Caplin Steriles USA Inc.; Civica, Inc.; Endo USA, Inc.; Eugia US LLCand 12 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Phenylephrine HCl units and claim line
Enter the dose given to get the J2371 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Phenylephrine HCl NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00404-9931-99 | J2371 | Henry Schein Inc. | 1 | 500 |
| 00641-6142-25 | J2371 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 12500 |
| 00641-6188-10 | J2371 | Hikma Pharmaceuticals USA Inc. | 10 × 5 | 25000 |
| 00641-6189-10 | J2371 | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 50000 |
| 00641-6229-25 | J2371 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 12500 |
| 00781-3422-92 | J2371 | Sandoz Inc. | 10 × 1 | 5000 |
| 00781-3458-95 | J2371 | Sandoz Inc. | 10 × 5 | 25000 |
| 00781-3466-70 | J2371 | Sandoz Inc. | 10 | 5000 |
| 00781-9227-95 | J2371 | Sandoz Inc. | 10 × 5 | 25000 |
| 00781-9228-70 | J2371 | Sandoz Inc. | 10 | 5000 |
| 23155-0620-41 | J2371 | Heritage Pharmaceuticals Inc. | 25 × 1 | 12500 |
| 25021-0315-01 | J2371 | Sagent Pharmaceuticals | 25 × 1 | 12500 |
| 25021-0315-98 | J2371 | Sagent Pharmaceuticals | 10 | 5000 |
| 25021-0315-99 | J2371 | Sagent Pharmaceuticals | 10 × 5 | 25000 |
| 42023-0214-10 | J2371 | Endo USA, Inc. | 10 × 5 | 25000 |
| 42023-0215-01 | J2371 | Endo USA, Inc. | 10 | 5000 |
| 51662-1249-01 | J2371 | HF Acquisition Co. LLC, DBA HealthFirst | 1 | 500 |
| 51662-1576-03 | J2371 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 1 | 12500 |
| 55150-0300-25 | J2371 | Eugia US LLC | 25 × 1 | 12500 |
| 55150-0301-10 | J2371 | Eugia US LLC | 10 × 5 | 25000 |
| 55150-0302-01 | J2371 | Eugia US LLC | 10 | 5000 |
| 61990-0211-03 | J2371 | Apollo Pharmaceuticals Inc. | 25 × 1 | 12500 |
| 61990-0212-02 | J2371 | Apollo Pharmaceuticals Inc. | 10 × 5 | 25000 |
| 61990-0213-01 | J2371 | Apollo Pharmaceuticals Inc. | 10 | 5000 |
| 63037-0173-25 | J2371 | Hikma Injectables USA Inc. | 25 × 10 | 1250 |
| 63037-0174-25 | J2371 | Hikma Injectables USA Inc. | 25 × 5 | 625 |
| 63323-0751-01 | J2371 | FreseniUS Kabi USA, LLC | 25 × 1 | 12500 |
| 63323-0751-05 | J2371 | FreseniUS Kabi USA, LLC | 5 | 2500 |
| 63323-0751-10 | J2371 | FreseniUS Kabi USA, LLC | 10 | 5000 |
| 63323-0751-13 | J2371 | FreseniUS Kabi USA, LLC | 25 × 1 | 12500 |
| 65145-0115-25 | J2371 | Caplin Steriles USA Inc. | 25 × 1 | 12500 |
| 70069-0801-25 | J2371 | Somerset Pharma, LLC | 25 × 1 | 12500 |
| 70069-0802-10 | J2371 | Somerset Pharma, LLC | 10 × 5 | 25000 |
| 70069-0803-01 | J2371 | Somerset Pharma, LLC | 10 | 5000 |
| 70069-0811-25 | J2371 | Somerset Pharma, LLC | 25 × 1 | 12500 |
| 70069-0812-10 | J2371 | Somerset Pharma, LLC | 10 × 5 | 25000 |
| 70069-0813-01 | J2371 | Somerset Pharma, LLC | 10 | 5000 |
| 70121-1577-05 | J2371 | Amneal Pharmaceuticals, LLC | 25 × 1 | 12500 |
| 70121-1578-07 | J2371 | Amneal Pharmaceuticals, LLC | 10 × 5 | 25000 |
| 70121-1579-01 | J2371 | Amneal Pharmaceuticals, LLC | 10 | 5000 |
| 70756-0621-25 | J2371 | Lifestar Pharma | 25 × 1 | 12500 |
| 70756-0622-10 | J2371 | Lifestar Pharma | 10 × 5 | 25000 |
| 70756-0623-86 | J2371 | Lifestar Pharma | 10 | 5000 |
| 71288-0807-02 | J2371 | Meitheal Pharmaceuticals Inc. | 25 × 1 | 12500 |
| 71288-0808-76 | J2371 | Meitheal Pharmaceuticals Inc. | 10 × 5 | 25000 |
| 71288-0808-77 | J2371 | Meitheal Pharmaceuticals Inc. | 10 | 5000 |
| 72205-0264-25 | J2371 | Novadoz Pharmaceuticals LLC | 25 × 1 | 12500 |
| 72205-0265-07 | J2371 | Novadoz Pharmaceuticals LLC | 10 × 5 | 25000 |
| 72205-0266-07 | J2371 | Novadoz Pharmaceuticals LLC | 10 × 10 | 50000 |
| 72485-0504-25 | J2371 | Armas Pharmaceuticals Inc. | 25 × 1 | 12500 |
| 72485-0505-10 | J2371 | Armas Pharmaceuticals Inc. | 10 × 5 | 25000 |
| 72485-0506-01 | J2371 | Armas Pharmaceuticals Inc. | 10 | 5000 |
| 72572-0570-10 | J2371 | Civica, Inc. | 10 × 10 | 50000 |
| 72572-0571-25 | J2371 | Civica, Inc. | 25 × 1 | 12500 |
| 81284-0211-25 | J2371 | Apollo Pharmaceuticals | 25 × 1 | 12500 |
| 81284-0212-10 | J2371 | Apollo Pharmaceuticals | 10 × 5 | 25000 |
| 81284-0213-01 | J2371 | Apollo Pharmaceuticals | 10 | 5000 |
Phenylephrine HCl: common questions
- What is the J-code for Phenylephrine HCl?
- Phenylephrine HCl is billed under HCPCS J2371 — Injection, phenylephrine hydrochloride, 20 micrograms. One billing unit is 20 mcg. CMS's crosswalk lists 57 Phenylephrine HCl NDCs under this code.
- How many J2371 billing units are in a package of Phenylephrine HCl?
- CMS lists 500 to 50,000 billing units per package, depending on the NDC, where one unit is 20 mcg. Units to report are based on the dose given, not the package.
- Is J2371 a CPT code?
- No. J2371 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.